ScreenerHero

PTIX Protagenic Therapeutics, Inc.

NAS · US · Technology · Biotechnology · protagenic.com
0.9141USD+15.71%Mkt Cap: 1.65M $P/E: —

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based i…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap1.65M USD
Enterprise Value827.88K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-5.53M USD
Revenue/Share—
Last Price0.9141 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees2
CountryUS
SectorTechnology
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.33
PEG—
EV/EBITDA-0.20
EV/Revenue—
P/S—
P/B0.81
EPS (TTM)2.23
EPS (Forward)-0.58
52W Range
0.140013% of range6.200
52W High6.200 USD
52W Low0.1400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-545.36%
ROA-282.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.22M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-423.33%
Net Debt-565.99K USD
Net Debt/EBITDA0.13
Balance Sheet
Debt/Equity—
Current Ratio0.66
Quick Ratio0.53
Book Value/Sh0.95 USD
Cash/Share0.31 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 27, 2016
Splits
Last Split1:14
Split DateMay 5, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.81M
Float1.72M
Insiders6.20%
Institutions3.69%
Short Interest
Short Ratio0.5d
Short % Float2.72%
Short % Out.2.62%
Shares Short50.77K
Short (prev mo.)53.43K
Technical
SMA 500.6663 (+37.2%)
SMA 2000.5915 (+54.5%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)12.66K
Avg Vol (10d)1.79K
Technical Indicators
RSI (14)59.8
MACD0.1258
MACD Signal0.1454
MACD Hist.-0.0196
BB Upper1.368 USD
BB Middle0.7944 USD
BB Lower0.2207 USD
BB Width144.43%
ATR (14)0.1180 USD
Vol Ratio (20d)1.25x